FDA
-
-
-
-
-
-
-
Theralase(R) Closes $CAN 2.66 Million Financing
-
-
-
-
-
-
-
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
-
-
-
-
-
-
-
Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
-
-
-
-
-
-
-
Theralase(R) Release’s 2Q2024 Financial Statements
-
-
-
-
-
-
-
Theralase(R) Provides Update on Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Theralase Releases Q222 Interim Financial Statements
-
-
-
-
-
-
-
Theralase(R) Releases Quarterly Newsletter
-
331,471 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

